Search Results - "Varki, Vinod"
-
1
Progress in the unraveling of the endoplasmic reticulum stress/autophagy pathway and cancer: Implications for future therapeutic approaches
Published in Drug resistance updates (01-06-2010)“…Abstract Given the inherent resistance to apoptosis that characterizes cancer, the targeting of alternative pathways is an attractive strategy to improve…”
Get full text
Journal Article -
2
MLN8054, A Small Molecule Inhibitor of Aurora Kinase A, Sensitizes Androgen-Resistant Prostate Cancer to Radiation
Published in International journal of radiation oncology, biology, physics (15-07-2011)“…Purpose To determine whether MLN8054, an Aurora kinase A (Aurora-A) inhibitor causes radiosensitization in androgen-insensitive prostate cancer cells in vitro…”
Get full text
Journal Article -
3
PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinoma
Published in Cancer Immunology, Immunotherapy (01-05-2018)“…Background To characterize the expression of co-signaling molecules PD-L1, PD-1, and B7-H3 in cutaneous squamous cell carcinoma (cSCC) by immune status…”
Get full text
Journal Article -
4
Definitive cetuximab-based (CRT-CX) vs. non-cetuximab based chemoradiation (CRT) in older patients with squamous cell carcinoma of the head and neck (HNSCC): Analysis of the SEER-Medicare linked database
Published in Journal of clinical oncology (20-05-2018)“…Abstract only…”
Get full text
Journal Article -
5
PD-L1, B7-H3, and PD-1 expression in immunocompetent versus immunosuppressed patients with advanced cutaneous squamous carcinoma (cSCC)
Published in Journal of clinical oncology (20-05-2016)“…Abstract only…”
Get full text
Journal Article -
6
Harnessing the cell death pathway for targeted cancer treatment
Published in American journal of cancer research (01-01-2011)“…Genotoxic agents have long targeted apoptotic cell death as a primary means of treating cancer. However, the presence of cellular defects in many cancers has…”
Get full text
Journal Article -
7
MLN8054, A Small Molecule Inhibitor of Aurora Kinase A, Sensitizes Androgen-Resistant Prostate Cancer to Radiation;Aurora kinase A; MLN8054; Prostate cancer; Radiation
Published in International journal of radiation oncology, biology, physics (15-07-2011)“…Purpose: To determine whether MLN8054, an Aurora kinase A (Aurora-A) inhibitor causes radiosensitization in androgen-insensitive prostate cancer cells in vitro…”
Get full text
Journal Article